Neurogene (NGNE) Share-based Compensation (2013 - 2026)
Neurogene's Share-based Compensation was $7.86 million in Q2 2026, up 130.7% from $3.41 million a year earlier and up 116.6% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Share-based Compensation (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurogene's Share-based Compensation was $18.22 million through Jun 30, 2026, up 46.7% year-over-year; for FY2025, it was $14.18 million, up 70.5% from FY2024.
- Share-based Compensation has now increased for three consecutive years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $8.32 million in FY2024 (+486.7%), $1.42 million in FY2023 (+13.3%), $1.25 million in FY2022 (-89.2%) and $11.56 million in FY2021 (+105.6%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q1 2013.
- Compared with a year earlier, Share-based Compensation was higher in seven of the last eight quarters, with growth averaging 208.5%.
- The best year-over-year quarter for Share-based Compensation over five years was Q4 2024 (growth of 600.6%); the worst was Q1 2023 (a decline of 88.0%).
- Per Business Quant data, NGNE's Share-based Compensation in the three quarters before Q2 2026 was $3.63 million (Q1 2026), $3.36 million (Q4 2025) and $3.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Neurogene | 642.28 Mn | 642.28 Mn | - | 7.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.86 Mn |
| Mar 31, 2026 | 3.63 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 386,000.00 |
| Jun 30, 2023 | 384,000.00 |
| Mar 31, 2023 | 293,000.00 |
| Dec 31, 2022 | -5.54 Mn |
| Sep 30, 2022 | 2.03 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.45 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Sep 30, 2021 | 3.21 Mn |
API Access
Neurogene Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();